We are live on
!
Find out more
SWM
Stockman Wealth Management Portfolio holdings
AUM
$968M
1-Year Est. Return
28.96%
This Fund
S&P 500
This Quarter
Est. Return
+10.94%
1 Year Est. Return
+28.96%
3 Year Est. Return
+73.45%
5 Year Est. Return
+87.45%
10 Year Est. Return
+221.15%
AUM
$229M
AUM Growth
+$19.5M
(+9.3%)
Cap. Flow
-$1.5M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
27.02%
Holding
155
New
6
Increased
34
Reduced
59
Closed
6
Avg Time Held
9.5
quarters
Top 10 Avg Time Held
7.1
quarters
Top 20 Avg Time Held
7.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$5.67M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.64M |
| 3 |
The Kraft Heinz Company
KHC
|
+$1.42M |
| 4 |
Phillips 66
PSX
|
+$781K |
| 5 |
AbbVie
ABBV
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$5.76M |
| 2 |
AstraZeneca
AZN
|
+$3.89M |
| 3 |
Oracle
ORCL
|
+$1.54M |
| 4 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$1.04M |
| 5 |
Merck
MRK
|
+$962K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.31% |
| 2 | Healthcare | 15.81% |
| 3 | Technology | 13.43% |
| 4 | Energy | 11.39% |
| 5 | Financials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$4.02T
| $7.49M | 3.27% |
63,464
+2,014
| +3% | +$220K |
2014 Q4
17 quarters
|
|
|
2
Merck
MRK
$359B
| $7.01M | 3.07% |
88,399
-12,866
| -13% | -$962K |
2014 Q4
17 quarters
|
|
3
Procter & Gamble
PG
$356B
| $6.63M | 2.9% |
63,722
-4,306
| -6% | -$419K |
2014 Q4
17 quarters
|
|
4
ExxonMobil
XOM
$708B
| $6.06M | 2.65% |
74,952
-1,806
| -2% | -$138K |
2014 Q4
17 quarters
|
|
5
Berkshire Hathaway Class B
BRK.B
$1.11T
| $5.89M | 2.57% |
29,327
+926
| +3% | +$187K |
2014 Q4
17 quarters
|
|
6
RTX Corp
RTX
$252B
| $5.89M | 2.57% |
72,587
+2,504
| +4% | +$190K |
2014 Q4
17 quarters
|
|
7
Intel
INTC
$536B
| $5.83M | 2.55% |
108,641
-9,920
| -8% | -$503K |
2014 Q4
17 quarters
|
|
|
8
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.2B
| $5.71M | 2.5% |
+186,998
| New | +$5.67M |
2019 Q1
0 quarters
|
|
9
AT&T
T
$154B
| $5.7M | 2.49% |
240,600
+2,224
| +0.9% | +$51.2K |
2014 Q4
17 quarters
|
|
10
Apple
AAPL
$4.98T
| $5.63M | 2.46% |
118,476
+4,596
| +4% | +$195K |
2014 Q4
17 quarters
|
|
11
Pfizer
PFE
$162B
| $5.35M | 2.34% |
132,720
-3,530
| -3% | -$141K |
2014 Q4
17 quarters
|
|
12
Cisco
CSCO
$455B
| $5.19M | 2.27% |
96,101
-9,880
| -9% | -$480K |
2014 Q4
17 quarters
|
|
13
Chevron
CVX
$422B
| $4.91M | 2.14% |
39,830
+292
| +0.7% | +$34.5K |
2014 Q4
17 quarters
|
|
14
JPMorgan Chase
JPM
$889B
| $4.58M | 2% |
45,260
+2,528
| +6% | +$260K |
2014 Q4
17 quarters
|
|
15
Occidental Petroleum
OXY
$61.1B
| $4.42M | 1.93% |
66,791
+5,042
| +8% | +$332K |
2014 Q4
17 quarters
|
|
16
American Express
AXP
$210B
| $4.34M | 1.9% |
39,736
-542
| -1% | -$57K |
2016 Q3
10 quarters
|
|
|
17
AbbVie
ABBV
$497B
| $4.25M | 1.86% |
52,721
+6,157
| +13% | +$504K |
2014 Q4
17 quarters
|
|
18
AB InBev
BUD
$154B
| $4.23M | 1.85% |
50,361
+4,327
| +9% | +$333K |
2018 Q1
4 quarters
|
|
19
Bank of New York Mellon
BNY
$96.9B
| $4.17M | 1.82% |
82,797
-5,368
| -6% | -$277K |
2014 Q4
17 quarters
|
|
|
20
Bristol-Myers Squibb
BMY
$118B
| $4.17M | 1.82% |
87,390
+73,085
| +511% | +$3.64M |
2014 Q4
17 quarters
|
|
21
DuPont de Nemours
DD
$17.5B
| $3.9M | 1.7% |
28,881
+3,029
| +12% | +$420K |
2018 Q1
4 quarters
|
|
|
22
Phillips 66
PSX
$112B
| $3.78M | 1.65% |
39,700
+8,214
| +26% | +$781K |
2018 Q2
3 quarters
|
|
23
Gilead Sciences
GILD
$187B
| $3.69M | 1.61% |
56,811
+3,405
| +6% | +$226K |
2016 Q2
11 quarters
|
|
24
Lowe's Companies
LOW
$104B
| $3.63M | 1.58% |
33,124
-1,208
| -4% | -$121K |
2014 Q4
17 quarters
|
|
25
DELISTED
Walgreens Boots Alliance
WBA
| $3.53M | 1.54% |
55,765
+5,868
| +12% | +$401K |
2017 Q3
6 quarters
|
|
Similar funds
DCM
LSA
IECM
RWM
NI
RWP
MWM
EWM
Stockman Wealth Management's Q1 2019 Portfolio in Review
As of Q1 2019, Stockman Wealth Management held 155 positions worth $229M, up 9.3% from $209M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Stockman Wealth Management's Q1 2019 filing shows 6 new, 34 increased, 59 reduced and 6 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Corporate Bond ETF: 186,998 shares worth $5.71M. The largest sale was iShares Floating Rate Bond ETF, an estimated $5.76M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Stockman Wealth Management's largest Q1 2019 buy was State Street SPDR Portfolio Short Term Corporate Bond ETF: 186,998 shares worth $5.71M.
- Stockman Wealth Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $3.64M increase.
- Stockman Wealth Management's biggest Q1 2019 reduction was AstraZeneca, cutting an estimated $3.89M.
- Stockman Wealth Management fully exited iShares Floating Rate Bond ETF in Q1 2019, selling an estimated $5.76M.
- Stockman Wealth Management's ten largest holdings make up 27% of its $229M portfolio in Q1 2019.
- Stockman Wealth Management opened 6 new positions and closed 6 in Q1 2019.
- Stockman Wealth Management's portfolio value rose 9.3% quarter-over-quarter to $229M.
Based on Stockman Wealth Management's 13F filing for Q1 2019, filed 7 May 2019.